公开(公告)号：US20090062233A1

公开(公告)日：2009-03-05

申请号：US12228029

申请日：2008-08-08

申请人： Xin Ji ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

IPC分类号： A61K31/718 ,  A61P17/02

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B31/18 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

摘要翻译： 当作为生物相容性改性淀粉应用于动物组织时，用于生物相容性止血，生物相容性粘附预防，组织愈合促进，可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。

公开(公告)号：US20130251996A1

公开(公告)日：2013-09-26

申请号：US13894396

申请日：2013-05-14

申请人： Xin JI ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

发明人： Xin JI ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

IPC分类号： A61L24/08 ,  A61L26/00 ,  A61K31/738 ,  A61K31/718

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

摘要翻译： 当将生物相容的改性淀粉作为生物相容的改性淀粉应用于动物的组织时，布置了改良的淀粉材料用于生物相容性止血，生物相容性粘附防止，组织愈合促进，可吸收的外科伤口密封和组织粘合。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。

公开(公告)号：US09687501B2

公开(公告)日：2017-06-27

申请号：US13894396

申请日：2013-05-14

申请人： Xin Ji ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi ,  Jianping Chen

IPC分类号： A61K31/718 ,  A61L24/00 ,  A61L26/00 ,  A61K9/14 ,  C08L3/18 ,  C08L3/04 ,  C08L89/06 ,  C08B31/12 ,  C08B31/08 ,  C08B31/02 ,  C08B33/04 ,  C08B31/10 ,  C08B31/16 ,  C08B35/02 ,  C08B33/06 ,  C08B35/06 ,  C08B35/04 ,  C08B33/02 ,  C08B31/04 ,  C08B30/20 ,  C08B31/00 ,  C08B30/00 ,  A61K31/738 ,  A61L24/08 ,  A61K45/06 ,  A61K9/19 ,  C08B31/06 ,  A61K9/00

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material is arranged for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

公开(公告)号：US08912168B2

公开(公告)日：2014-12-16

申请号：US14018895

申请日：2013-09-05

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  A61K31/738 ,  C08B31/16 ,  C08B30/00 ,  A61L24/08 ,  A61L26/00

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

摘要翻译： 当作为生物相容性改性淀粉应用于动物组织时，用于生物相容性止血，生物相容性粘附预防，组织愈合促进，可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。

公开(公告)号：US10195312B2

公开(公告)日：2019-02-05

申请号：US15427801

申请日：2017-02-08

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  A61L31/04 ,  C08B31/08 ,  C08B31/02 ,  C08B33/04 ,  C08B31/10 ,  C08B31/16 ,  C08B35/02 ,  C08B33/06 ,  C08B35/06 ,  C08B35/04 ,  C08B33/02 ,  C08B31/12 ,  C08B31/04 ,  C08B30/20 ,  C08B31/00 ,  C08B31/18 ,  C08B30/00 ,  A61K31/738 ,  A61L24/08 ,  A61L26/00 ,  A61K45/06 ,  A61K9/14 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  A61K9/00 ,  A61K9/19 ,  A61L24/00 ,  A61L24/10 ,  A61L31/12

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

公开(公告)号：US10076590B2

公开(公告)日：2018-09-18

申请号：US15359255

申请日：2016-11-22

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  A61L31/04 ,  C08B31/08 ,  C08B31/02 ,  C08B33/04 ,  C08B31/10 ,  C08B31/16 ,  C08B35/02 ,  C08B33/06 ,  C08B35/06 ,  C08B35/04 ,  C08B33/02 ,  C08B31/12 ,  C08B31/04 ,  C08B30/20 ,  C08B31/00 ,  C08B30/00 ,  A61K31/738 ,  A61L24/08 ,  A61L26/00 ,  A61K45/06 ,  A61K9/14 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  A61K9/00 ,  A61K9/19 ,  A61L24/00 ,  A61L24/10 ,  A61L31/12

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B31/18 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

公开(公告)号：US08575132B2

公开(公告)日：2013-11-05

申请号：US13740033

申请日：2013-01-11

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  A61F13/02 ,  A61F13/53

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

公开(公告)号：US09533005B2

公开(公告)日：2017-01-03

申请号：US14322861

申请日：2014-07-02

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  C08B31/00 ,  C08B31/08 ,  C08B31/02 ,  C08B33/04 ,  C08B31/10 ,  C08B31/16 ,  C08B35/02 ,  C08B33/06 ,  C08B35/06 ,  C08B35/04 ,  C08B33/02 ,  C08B31/12 ,  C08B31/04 ,  C08B30/20 ,  C08B30/00 ,  A61K31/738 ,  A61L24/08 ,  A61L26/00 ,  A61K45/06

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

摘要翻译： 当作为生物相容性改性淀粉应用于动物组织时，用于生物相容性止血，生物相容性粘附预防，组织愈合促进，可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。

公开(公告)号：US20150037426A1

公开(公告)日：2015-02-05

申请号：US14322861

申请日：2014-07-02

申请人： Xin Ji

发明人： Xin Ji ,  Cheng Xing ,  Xueshen Shi

IPC分类号： A61K31/718 ,  A61K45/06

CPC分类号： A61L31/042 ,  A61K9/0014 ,  A61K9/14 ,  A61K9/19 ,  A61K31/718 ,  A61K31/738 ,  A61K45/06 ,  A61L24/0015 ,  A61L24/0036 ,  A61L24/0073 ,  A61L24/08 ,  A61L24/104 ,  A61L26/0023 ,  A61L26/0085 ,  A61L31/045 ,  A61L31/125 ,  A61L2300/406 ,  A61L2400/04 ,  A61L2430/34 ,  C08B30/00 ,  C08B30/20 ,  C08B31/00 ,  C08B31/003 ,  C08B31/02 ,  C08B31/04 ,  C08B31/08 ,  C08B31/10 ,  C08B31/12 ,  C08B31/16 ,  C08B33/02 ,  C08B33/04 ,  C08B33/06 ,  C08B35/02 ,  C08B35/04 ,  C08B35/06 ,  C08L3/04 ,  C08L3/18 ,  C08L89/06 ,  Y10T428/2982

摘要： A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

摘要翻译： 当作为生物相容性改性淀粉应用于动物组织时，用于生物相容性止血，生物相容性粘附预防，组织愈合促进，可吸收外科伤口密封和组织粘合的改性淀粉材料。 改性淀粉材料产生止血，减少伤口出血，外渗和组织渗出，保持伤口表面或伤口相对湿润或干燥，抑制细菌生长和炎症反应，减少组织炎症，缓解患者疼痛 。 不参与止血活性的任何多余的改性淀粉容易溶解，并在操作期间通过盐水冲洗冲洗掉。 手术伤口治疗后，对伤口，创伤和紧急伤口进行治疗，改性淀粉止血材料被身体快速吸收，无与纱布和绷带去除有关的并发症。

公开(公告)号：USD991478S1

公开(公告)日：2023-07-04

申请号：US29884503

申请日：2023-02-13

申请人： Cheng Xing

设计人： Cheng Xing ,  Yuhang Yan ,  Lianxin Zhao

摘要： FIG. 1 is a front, right, and top perspective view of a massage ball, showing our design.
FIG. 2 is a rear, left and bottom perspective view thereof.
FIG. 3 is a front elevation view thereof.
FIG. 4 is a rear elevation view thereof.
FIG. 5 is a left side elevation view thereof.
FIG. 6 is a right side elevation view thereof.
FIG. 7 is a top plan view thereof.
FIG. 8 is a bottom plan view thereof.
FIG. 9 is an enlarged view of detail 9 in FIG. 1.
FIG. 10 is an enlarged view of detail 10 in FIG. 2.
FIG. 11 is an exploded front, right, and top perspective view of the massage ball; and,
FIG. 12 is another exploded front, right, and top perspective view of the massage ball.
The broken lines depict portions of the massage ball that form no part of the claimed design.
The dot-dash broken lines in FIGS. 1, 2, 9 and 10 depict the boundaries of the enlargements that form no part of the claimed design.